A comparison of the RA patients with the non-RA patients as a whole (n=81) showed the RA group had significantly higher total tenascin-C than other diseases (p=0.026); however, there was no significant difference between the RA group compared to any individual disease (Figure 3A). This evidence concerns the gene TNC and rheumatoid arthritis.